142 related articles for article (PubMed ID: 792853)
1. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
Birkeland SA
Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
[TBL] [Abstract][Full Text] [Related]
2. A controlled clinical trial of treatment with ALG in established rejection of renal allografts.
Birkeland SA
Acta Med Scand; 1975 Dec; 198(6):489-96. PubMed ID: 1108600
[TBL] [Abstract][Full Text] [Related]
3. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
Taylor HE; Ackman CF; Horowitz I
Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
[TBL] [Abstract][Full Text] [Related]
4. Multicenter comparison of rejection reversal: rabbit anti-human lymphocyte serum (ATS) versus horse anti-human lymphocyte globulin (ATGAM).
Johnson K; Niblack G; Richie R; MacDonell R; Nylander W; Walker P; Sterling W; Ross G; Humphries A; Peterson D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1734-5. PubMed ID: 2652567
[No Abstract] [Full Text] [Related]
5. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
Jakobsen A; Sødal G; Flatmark A; Thorsby E
Scand J Urol Nephrol Suppl; 1977; (42):94-6. PubMed ID: 356233
[TBL] [Abstract][Full Text] [Related]
6. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
7. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
Sansom JR; Barnes AD; Hall CL
Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
[TBL] [Abstract][Full Text] [Related]
8. Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts.
Putnam CW; Bell RH; Beart RW; Anderson JT; Weil R
Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847
[TBL] [Abstract][Full Text] [Related]
9. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
11. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
[No Abstract] [Full Text] [Related]
12. Antilymphocyte globulin and renal transplantation.
Tagnon A
Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with antilymphocyte globulin (ALG) and evolution of renal transplant: observations of 42 cases].
Civati G; Grillo C; Di Belgioioso GB; Rovati C; Surian M; Busnach G; Broggi L; Ferrari L
Boll Ist Sieroter Milan; 1978 May; 57(2):165-72. PubMed ID: 365193
[TBL] [Abstract][Full Text] [Related]
14. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
Venkat KK; Kupin W; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
[No Abstract] [Full Text] [Related]
15. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation.
Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE
Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232
[TBL] [Abstract][Full Text] [Related]
16. Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A.
O'Donoghue DJ; Johnson RW; Mallick NP; Gokal R; Ballardie FW; Bakran A; Pearson R; Scott P
Transplant Proc; 1989 Feb; 21(1 Pt 2):1736-7. PubMed ID: 2652568
[No Abstract] [Full Text] [Related]
17. Controlled trial of antilymphocyte globulin in cadaveric transplantation.
Jakobsen J; Flatmark A; Sodal G; Thorsby E
Postgrad Med J; 1976; 52(5 Suppl):72-4. PubMed ID: 792850
[TBL] [Abstract][Full Text] [Related]
18. Reversal of acute renal allograft rejection with adjunctive AG therapy.
Filo RS; Smith EJ; Leapman SB
Transplant Proc; 1981 Mar; 13(1 Pt 1):482-90. PubMed ID: 7022879
[TBL] [Abstract][Full Text] [Related]
19. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of immunological findings for the survival time of kidney transplants with antilymphocyte globulin therapy].
Bullinger W; Hammer C; Land W; Welter H
Chir Forum Exp Klin Forsch; 1979; ():319-24. PubMed ID: 378592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
